Boothbay Fund Management’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.73M Buy
36,308
+19,595
+117% +$908K 0.02% 791
2026
Q1
$732K Buy
16,713
+11,514
+221% +$525K 0.01% 1126
2025
Q4
$231K Sell
5,199
-2,871
-36% -$124K ﹤0.01% 1597
2025
Q3
$341K Buy
+8,070
New +$325K 0.01% 1377
2025
Q1
– Sell
-5,638
Closed -$213K – 1672
2024
Q4
$213K Sell
5,638
-126,890
-96% -$5.07M 0.01% 1186
2024
Q3
$5.39M Buy
+132,528
New +$5.01M 0.12% 231
2023
Q4
– Sell
-13,688
Closed -$454K – 1878
2023
Q3
$454K Sell
13,688
-54,306
-80% -$1.73M 0.01% 1069
2023
Q2
$2.09M Buy
+67,994
New +$1.96M 0.05% 546
2022
Q4
– Sell
-52,999
Closed -$1.56M – 2327
2022
Q3
$1.56M Buy
+52,999
New +$1.66M 0.04% 681
2017
Q1
– Sell
-6,852
Closed -$262K – 898
2016
Q4
$262K Buy
+6,852
New +$211K 0.06% 464

Other funds holding OHI

Boothbay Fund Management's OHI Position: Q2 2026 in Review

Boothbay Fund Management increased its Omega Healthcare (OHI) stake by 117% in Q2 2026, buying an estimated $908K and bringing the position to 36,308 shares worth $1.73M. The position accounts for 0.02% of the portfolio, ranked #791.

Boothbay Fund Management first reported a position in OHI in Q4 2016 and has held it in 10 quarters since. The position peaked at $5.39M in Q3 2024. 763 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • Boothbay Fund Management held 36,308 shares of Omega Healthcare worth $1.73M as of Q2 2026.
  • Boothbay Fund Management bought 19,595 Omega Healthcare shares in Q2 2026, an estimated $908K.
  • Omega Healthcare made up 0.02% of Boothbay Fund Management's portfolio in Q2 2026, its #791 holding.
  • Boothbay Fund Management first reported a position in Omega Healthcare in Q4 2016 and has held it in 10 quarters since.
  • Boothbay Fund Management's Omega Healthcare position peaked at $5.39M in Q3 2024.
  • 763 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.